These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23173591)

  • 1. Insulin resistance and endothelial dysfunction: a mutual relationship in cardiometabolic risk.
    Del Turco S; Gaggini M; Daniele G; Basta G; Folli F; Sicari R; Gastaldelli A
    Curr Pharm Des; 2013; 19(13):2420-31. PubMed ID: 23173591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insulin resistance and vascular function].
    Naruse M; Tanabe A; Takagi S; Tago K; Takano K
    Nihon Rinsho; 2000 Feb; 58(2):344-7. PubMed ID: 10707556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction.
    Han SH; Quon MJ; Koh KK
    Curr Opin Lipidol; 2007 Feb; 18(1):58-65. PubMed ID: 17218834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in cardiovascular and endocrine-metabolic diseases: an update.
    Davel AP; Wenceslau CF; Akamine EH; Xavier FE; Couto GK; Oliveira HT; Rossoni LV
    Braz J Med Biol Res; 2011 Sep; 44(9):920-32. PubMed ID: 21956535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal insulin signaling: early detection of silent coronary artery disease-erectile dysfunction?
    Potenza MA; Montagnani M
    Curr Pharm Des; 2008; 14(35):3737-48. PubMed ID: 19128226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated view of insulin resistance and endothelial dysfunction.
    Muniyappa R; Iantorno M; Quon MJ
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):685-711, ix-x. PubMed ID: 18775359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.
    Kim JA; Montagnani M; Koh KK; Quon MJ
    Circulation; 2006 Apr; 113(15):1888-904. PubMed ID: 16618833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin action and insulin resistance in vascular endothelium.
    Muniyappa R; Quon MJ
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):523-30. PubMed ID: 17563474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders.
    Janus A; Szahidewicz-Krupska E; Mazur G; Doroszko A
    Mediators Inflamm; 2016; 2016():3634948. PubMed ID: 27413253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E; DeFronzo RA
    Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal relationships between insulin resistance and endothelial dysfunction: insights from therapeutic interventions.
    Quon MJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):305-12. PubMed ID: 16859113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and endothelial dysfunction.
    Yki-Järvinen H
    Best Pract Res Clin Endocrinol Metab; 2003 Sep; 17(3):411-30. PubMed ID: 12962694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, cardiovascular stiffening and cardiovascular disease.
    Hill MA; Yang Y; Zhang L; Sun Z; Jia G; Parrish AR; Sowers JR
    Metabolism; 2021 Jun; 119():154766. PubMed ID: 33766485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular actions of insulin.
    Muniyappa R; Montagnani M; Koh KK; Quon MJ
    Endocr Rev; 2007 Aug; 28(5):463-91. PubMed ID: 17525361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin as a vascular hormone: implications for the pathophysiology of cardiovascular disease.
    Cleland SJ; Petrie JR; Ueda S; Elliott HL; Connell JM
    Clin Exp Pharmacol Physiol; 1998; 25(3-4):175-84. PubMed ID: 9590566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: an update.
    Zhang H; Dellsperger KC; Zhang C
    Basic Res Cardiol; 2012 Jan; 107(1):237. PubMed ID: 22189563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases.
    Incalza MA; D'Oria R; Natalicchio A; Perrini S; Laviola L; Giorgino F
    Vascul Pharmacol; 2018 Jan; 100():1-19. PubMed ID: 28579545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study.
    van Sloten TT; Henry RM; Dekker JM; Nijpels G; Unger T; Schram MT; Stehouwer CD
    Hypertension; 2014 Dec; 64(6):1299-305. PubMed ID: 25225211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between insulin resistance and the development of cardiovascular disease.
    Ormazabal V; Nair S; Elfeky O; Aguayo C; Salomon C; Zuñiga FA
    Cardiovasc Diabetol; 2018 Aug; 17(1):122. PubMed ID: 30170598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.